Tu1693 LACTULOSE WITHDRAWAL CAN POTENTIATE BREAKTHROUGH OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS CONTROLLED WITH RIFAXIMIN PLUS LACTULOSE THERAPY: A POST HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
Year: 2020
Type: conference-abstract
Source: Gastroenterology
Authors: Jasmohan S. Bajaj, Sundaram Vinay, Catherine T. Frenette, Zeev Heimanson, Robert J. Israel, Arun J. Sanyal
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3026542397